Feedback

The protective role of cannabidiol in stress-induced liver injury: modulating oxidative stress and mitochondrial damage

Affiliation
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital ,Shenzhen ,China
Huang, Chengyu;
Affiliation
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital ,Shenzhen ,China
Liang, Huichao;
Affiliation
School of Pharmacy, Guangdong Pharmaceutical University ,Guangzhou ,China
Liang, Xiaohua;
Affiliation
School of Pharmacy, Guangdong Pharmaceutical University ,Guangzhou ,China
Liu, Yueyi;
Affiliation
School of Pharmacy, Guangdong Pharmaceutical University ,Guangzhou ,China
Wang, Jiaoling;
Affiliation
School of Pharmacy, Guangdong Pharmaceutical University ,Guangzhou ,China
Jiang, Haoran;
Affiliation
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital ,Shenzhen ,China
Kou, Xinhui;
Affiliation
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital ,Shenzhen ,China
Chen, Jun;
Affiliation
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital ,Shenzhen ,China
Huang, Lili

Background Stress-induced liver injury, resulting from acute or chronic stress, is associated with oxidative stress and inflammation. The endocannabinoid system, particularly cannabinoid receptor 2 (CB 2 R), plays a crucial role in liver damage. However, there are currently no clinical drugs targeting CB 2 R for liver diseases. Cannabidiol (CBD), a CB2R agonist, possesses anti-inflammatory and antioxidant properties. This study aims to investigate the pharmacological effects of CBD in a mouse model of stress-induced liver injury. Methods We employed a mouse model of stress-induced liver injury to evaluate the protective effects of CBD. Assessments included histopathological analysis, cytokine detection via ELISA, protein expression analysis using immunohistochemistry and Western blot, and gene transcription differential analysis. Transmission electron microscopy was utilized to observe mitochondrial morphology. Additionally, we examined the expression levels of CB 2 R, SLC7A11, α-SMA, and ACSL4 proteins to elucidate the mechanisms underlying CBD’s effects. Results CBD exhibited significant protective effects against stress-induced liver injury in mice. Decreases in liver function indicators (including Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT)) and inflammatory cytokines (such as IL-1β and Tumor Necrosis Factor-alpha (TNF-α)) were observed. CBD enhanced CB 2 R expression and reduced α-SMA levels, mitigating liver fibrosis. It also decreased ACSL4 levels, increased SOD and GSH-Px activities, and upregulated SLC7A11 protein expression. Furthermore, CBD improved mitochondrial morphology, indicating a reduction in oxidative cell death. Conclusion CBD activates the CB 2 R/α-SMA pathway to modulate liver inflammation and fibrosis. Through the SLC7A11/ACSL4 signaling pathway, CBD alleviates oxidative stress in stress-induced liver injury, enhances mitochondrial morphology, and reduces liver damage. These findings provide a theoretical basis for the potential application of CBD in the prevention and treatment of stress-induced liver injury.

Graphical Abstract The protective role of CBD in stress-induced liver injury. (Image created with Figdraw, Export code: YTUOT76e0e).

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Huang, Liang, Liang, Liu, Wang, Jiang, Kou, Chen and Huang.

Use and reproduction: